Prognostic and predictive factors for lung cancer
نویسندگان
چکیده
منابع مشابه
Prognostic and predictive factors in colorectal cancer.
Prognostication of newly diagnosed colorectal cancer (CRC) predominantly relies on stage as defined by the UICC-TNM and American Joint Committee on Cancer classifications. Tumour extent, lymph node status, tumour grade and the assessment of lymphatic and venous invasion are still the most important morphological prognostic factors. Evidence suggests that tumour budding and tumour border configu...
متن کاملSurvival and Prognostic Factors in Small Cell Lung Cancer Patients in Turkey
Background: Small cell lung cancer (SCLC) is a highly aggressive tumor. Objective: To evaluate the survival and time to progression of patients with SCLC admitted to a chest disease center in Istanbul, Turkey. Methods: Based on the reports of a pulmonary oncology clinic, data regarding performance status (PS), clinical stage of disease, treatment, time to progression and survival of 67 patients...
متن کاملPrognostic and predictive factors.
Prognostic factors are key elements for medical oncologists to select, among the group of patients with early breast cancer, those who are candidates for an adjuvant treatment based on their risk of tumor relapse. Predictive factors drive the decision of which type(s) of treatment should be given. If we perform a literature search on prognostic and predictive factors in breast cancer we immedia...
متن کاملMolecular Prognostic and Predictive Markers in Lung Cancer
Lung cancer is the most common type of cancer in the Western World and there has been systematic effort to find markers with prognostic and predictive significance. Molecular biology is lately being used in order to find markers that are highly sensitive, specific and associated with survival. This review presents recent data regarding the numerous studies that have been conducted in this field...
متن کاملMolecular Markers with Predictive and Prognostic Relevance in Lung Cancer
Lung cancer accounts for the majority of cancer-related deaths worldwide of which non-small-cell lung carcinoma alone takes a toll of around 85%. Platinum-based therapy is the stronghold for lung cancer at present. The discovery of various molecular alterations that underlie lung cancer has contributed to the development of specifically targeted therapies employing specific mutation inhibitors....
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Breathe
سال: 2012
ISSN: 1810-6838
DOI: 10.1183/20734735.006911